CROS NT Launches CROScheck at DIA Chicago
CHAPEL HILL, NC- Jun 20, 2017 - CROS NT, a global Clinical Research Organization (CRO), announced CROScheck™, a clinical trial solution to deliver sponsors the biometrics oversight needed to assess data integrity from multiple sites. By incorporating data management and statistical methodology along with technology, sponsors can take a modular or full risk-based approach.
Visit CROS NT at DIA Booth #1040 to learn more about how CROScheck™ addresses the challenges that Sponsors encounter within the new GCP E6(R2) Guidelines that have recently come into effect. This is especially important as the guidelines state that the ultimate responsibility for the quality and integrity of the trial data will always reside with the sponsor even if fully outsourced to a CRO.
"CROScheck™ brings together leading edge intellectual property, powerful technology and world class expertise to service a growing need across our customer base. It gives Sponsors the necessary oversight and confidence to meet global regulatory requirements,” said Andrew MacGarvey, CEO of CROS NT. “Central monitoring is increasingly becoming a critical component of clinical studies. CROScheck™ will allow our customers to focus resources and budget in the most effective way," he added.
ABOUT CROS NT
Founded in 1992, CROS NT is a data-driven Contract Research Organization (CRO) providing services from feasibility to clinical study reporting for Phases I-IV and medical device trials. CROS NT's services include regulatory consultancy, monitoring, data management, biostatistics programming & analysis, pharmacovigilance, and medical writing-and accompanying eClinical applications (data visualization, EDC, IWRS, eCOA/ePRO etc.). All services are underpinned by clinical and biometrics project management with offices located in Europe, the USA and India.
Media Contact:
Dawn Fontaine
Ripple Effect Communications
dawn@rippleeffectpr.com
508-353-3777
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
The Role of Human Oversight With Artificial Intelligence in Clinical Research
April 12th 2024In the fifth and final part of this video interview with ACT editor Andy Studna, Stephen Pyke, chief clinical data and digital officer, Parexel, highlights the importance of human oversight when using artificial intelligence to aid in decision making.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
